Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Howard

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Cell Metabolism|January 26, 2010
Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesityXiao-Ming Guan, Howard Chen, Peter H Dobbelaar, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityJian Liu, Shuwen He, Tianying Jian, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonistsShuwen He, Peter H Dobbelaar, Jian Liu, et al.
Nature Structural & Molecular Biology|June 6, 2017
Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40Jun Lu, Noel Byrne, John Wang, et al.
Science (New York, N.Y.)|July 6, 2019
Targeting a ceramide double bond improves insulin resistance and hepatic steatosisBhagirath Chaurasia, Trevor S Tippetts, Rafael Mayoral Monibas, et al.
ACS Medicinal Chemistry Letters|July 23, 2014
Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonistsShuwen He, Zhong Lai, Zhixiong Ye, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2002
A role for the melanocortin 4 receptor in sexual functionLex H T Van der Ploeg, William J Martin, Andrew D Howard, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 DiabetesShrenik K Shah, Shuwen He, Liangqin Guo, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonistsShuwen He, Peter H Dobbelaar, Liangqin Guo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 DiabetesShuwen He, Zhixiong Ye, Quang Truong, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cell Metabolism|January 26, 2010
Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesityXiao-Ming Guan, Howard Chen, Peter H Dobbelaar, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityJian Liu, Shuwen He, Tianying Jian, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonistsShuwen He, Peter H Dobbelaar, Jian Liu, et al.
Nature Structural & Molecular Biology|June 6, 2017
Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40Jun Lu, Noel Byrne, John Wang, et al.
Science (New York, N.Y.)|July 6, 2019
Targeting a ceramide double bond improves insulin resistance and hepatic steatosisBhagirath Chaurasia, Trevor S Tippetts, Rafael Mayoral Monibas, et al.
ACS Medicinal Chemistry Letters|July 23, 2014
Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonistsShuwen He, Zhong Lai, Zhixiong Ye, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2002
A role for the melanocortin 4 receptor in sexual functionLex H T Van der Ploeg, William J Martin, Andrew D Howard, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 DiabetesShrenik K Shah, Shuwen He, Liangqin Guo, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonistsShuwen He, Peter H Dobbelaar, Liangqin Guo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 DiabetesShuwen He, Zhixiong Ye, Quang Truong, et al.
Pageof 6